284 related articles for article (PubMed ID: 35145760)
21. Broad Spectrum epidemiological contribution of cannabis and other substances to the teratological profile of northern New South Wales: geospatial and causal inference analysis.
Reece AS; Hulse GK
BMC Pharmacol Toxicol; 2020 Nov; 21(1):75. PubMed ID: 33183341
[TBL] [Abstract][Full Text] [Related]
22. Clinical Epigenomic Explanation of the Epidemiology of Cannabinoid Genotoxicity Manifesting as Transgenerational Teratogenesis, Cancerogenesis and Aging Acceleration.
Reece AS; Hulse GK
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834053
[TBL] [Abstract][Full Text] [Related]
23. Epidemiological association of cannabinoid- and drug- exposures and sociodemographic factors with limb reduction defects across USA 1989-2016: A geotemporospatial study.
Reece AS; Hulse GK
Spat Spatiotemporal Epidemiol; 2022 Jun; 41():100480. PubMed ID: 35691647
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of Δ8THC-Related Carcinogenesis in USA: A Panel Regression and Causal Inferential Study.
Reece AS; Hulse GK
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805384
[TBL] [Abstract][Full Text] [Related]
25. Canadian Cannabis Consumption and Patterns of Congenital Anomalies: An Ecological Geospatial Analysis.
Reece AS; Hulse GK
J Addict Med; 2020; 14(5):e195-e210. PubMed ID: 32187114
[TBL] [Abstract][Full Text] [Related]
26. Geospatiotemporal and causal inference study of cannabis and other drugs as risk factors for female breast cancer USA 2003-2017.
Reece AS; Hulse GK
Environ Epigenet; 2022; 8(1):dvac006. PubMed ID: 35386387
[TBL] [Abstract][Full Text] [Related]
27. Cannabis Teratology Explains Current Patterns of Coloradan Congenital Defects: The Contribution of Increased Cannabinoid Exposure to Rising Teratological Trends.
Reece AS; Hulse GK
Clin Pediatr (Phila); 2019 Sep; 58(10):1085-1123. PubMed ID: 31288542
[TBL] [Abstract][Full Text] [Related]
28. Co-occurrence across time and space of drug- and cannabinoid- exposure and adverse mental health outcomes in the National Survey of Drug Use and Health: combined geotemporospatial and causal inference analysis.
Reece AS; Hulse GK
BMC Public Health; 2020 Nov; 20(1):1655. PubMed ID: 33148213
[TBL] [Abstract][Full Text] [Related]
29. Impact of converging sociocultural and substance-related trends on US autism rates: combined geospatiotemporal and causal inferential analysis.
Reece AS; Hulse GK
Eur Arch Psychiatry Clin Neurosci; 2023 Apr; 273(3):699-717. PubMed ID: 35779123
[TBL] [Abstract][Full Text] [Related]
30. Environmental and individual exposure and the risk of congenital anomalies: a review of recent epidemiological evidence.
Baldacci S; Gorini F; Santoro M; Pierini A; Minichilli F; Bianchi F
Epidemiol Prev; 2018; 42(3-4 Suppl 1):1-34. PubMed ID: 30066535
[TBL] [Abstract][Full Text] [Related]
31. Causal inference multiple imputation investigation of the impact of cannabinoids and other substances on ethnic differentials in US testicular cancer incidence.
Reece AS; Hulse GK
BMC Pharmacol Toxicol; 2021 Jul; 22(1):40. PubMed ID: 34246312
[TBL] [Abstract][Full Text] [Related]
32. Epidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer development.
Reece AS; Hulse GK
Sci Rep; 2021 Jul; 11(1):13892. PubMed ID: 34230557
[TBL] [Abstract][Full Text] [Related]
33. Chromothripsis and epigenomics complete causality criteria for cannabis- and addiction-connected carcinogenicity, congenital toxicity and heritable genotoxicity.
Reece AS; Hulse GK
Mutat Res; 2016 Jul; 789():15-25. PubMed ID: 27208973
[TBL] [Abstract][Full Text] [Related]
34. Novel Insights into Potential Cannabis-Related Cancerogenesis from Recent Key Whole Epigenome Screen of Cannabis Dependence and Withdrawal: Epidemiological Commentary and Explication of Schrott et al.
Reece AS; Hulse GK
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672773
[TBL] [Abstract][Full Text] [Related]
35. Epigenomic and Other Evidence for Cannabis-Induced Aging Contextualized in a Synthetic Epidemiologic Overview of Cannabinoid-Related Teratogenesis and Cannabinoid-Related Carcinogenesis.
Reece AS; Hulse GK
Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554603
[TBL] [Abstract][Full Text] [Related]
36. Amphetamine-Type Stimulant Dependence and Association with Concurrent Use of Cocaine, Alcohol, and Cannabis: A Cross-Sectional Study.
Berndt S; Rosenkranz M; Martens MS; Verthein U
Eur Addict Res; 2022; 28(2):113-121. PubMed ID: 34788752
[TBL] [Abstract][Full Text] [Related]
37. Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats.
Gorriti MA; Rodríguez de Fonseca F; Navarro M; Palomo T
Eur J Pharmacol; 1999 Jan; 365(2-3):133-42. PubMed ID: 9988095
[TBL] [Abstract][Full Text] [Related]
38. Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates.
Manthey J; Freeman TP; Kilian C; López-Pelayo H; Rehm J
Lancet Reg Health Eur; 2021 Nov; 10():100227. PubMed ID: 34806072
[TBL] [Abstract][Full Text] [Related]
39. Adverse effects of cannabis.
Prescrire Int; 2011 Jan; 20(112):18-23. PubMed ID: 21462790
[TBL] [Abstract][Full Text] [Related]
40. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
